VIVACE THERAPEUTICS INC has a total of 22 patent applications. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are DDSA PHARMACEUTICALS LTD, RES LAB DR C JANSSEN NV and LUMIERE LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 3 | |
#5 | Australia | 2 | |
#6 | China | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lin Tracy Tzu-Ling Tang | 21 |
#2 | Konradi Andrei W | 21 |
#3 | Konradi Andrei | 1 |
#4 | Coburn Craig | 1 |
#5 | Lin Tracy | 1 |
#6 | Shen Wang | 1 |
#7 | Vacca Joseph | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020214734A1 | Bicyclic compounds | |
WO2020097389A1 | Bicyclic compounds | |
WO2019222431A1 | Oxadiazole compounds | |
CA3084648A1 | Benzocarbonyl compounds | |
CN111542315A | Benzosulfonyl compounds | |
WO2018204532A1 | Non-fused tricyclic compounds | |
WO2017058716A1 | Tricyclic compounds |